Raising the bar for cancer therapy models

This publication has 11 references indexed in Scilit:

• Assessing therapeutic responses in Kras mutant cancers using genetically engineered mouse models
  Nature Biotechnology, 2010
• Comparative Impact of Trastuzumab and Cyclophosphamide on HER-2–Positive Human Breast Cancer Xenografts
  Clinical Cancer Research, 2009
• Recent Developments of Targeted Therapies in the Treatment of Non-Small Cell Lung Cancer
  Current Drug Discovery Technologies, 2009
• Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis
  Published by Elsevier ,2009
• Maximizing mouse cancer models
  Nature Reviews Cancer, 2007
• Murine Models to Evaluate Novel and Conventional Therapeutic Strategies for Cancer
  The American Journal of Pathology, 2007
• Highly Efficacious Nontoxic Preclinical Treatment for Advanced Metastatic Breast Cancer Using Combination Oral UFT-Cyclophosphamide Metronomic Chemotherapy
  Cancer Research, 2006
• Can the pharmaceutical industry reduce attrition rates?
  Nature Reviews Drug Discovery, 2004
• Integrating pharmacology and in vivo cancer models in preclinical and clinical drug development
  European Journal Of Cancer, 2004
• Evaluation of antitumor activity in a human breast tumor/nude mouse model with a special emphasis on treatment dose
  Cancer, 1989